(Q44598086)

English

Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis (English)

1 reference

Europe PubMed Central

4 December 2017

author name string

Yossi Gilgun-Sherki

1

1 reference

Europe PubMed Central

4 December 2017

Hana Panet

2

1 reference

Europe PubMed Central

4 December 2017

Vered Holdengreber

3

1 reference

Europe PubMed Central

4 December 2017

Ronit Mosberg-Galili

4

1 reference

Europe PubMed Central

4 December 2017

Daniel Offen

5

1 reference

Europe PubMed Central

4 December 2017

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14512144

14 March 2024

publication date

1 October 2003

1 reference

Europe PubMed Central

4 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0168010203002177?httpAccept=text/xml

1 reference

10.1016/S0168-0102(03)00217-7

https://api.crossref.org/works/10.1016/S0168-0102(03)00217-7

14 March 2024

https://api.elsevier.com/content/article/PII:S0168010203002177?httpAccept=text/plain

1 reference

10.1016/S0168-0102(03)00217-7

https://api.crossref.org/works/10.1016/S0168-0102(03)00217-7

14 March 2024

Neuroscience Research

1 reference

Europe PubMed Central

4 December 2017

47

1 reference

Europe PubMed Central

4 December 2017

2

1 reference

Europe PubMed Central

4 December 2017

201-207

1 reference

Europe PubMed Central

4 December 2017

Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Axonal damage in acute multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glatiramer acetate inhibition of tumor necrosis factor-alpha-induced RANTES expression and release from U-251 MG human astrocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Demyelination and axonal damage in a non-human primate model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of action of glatiramer acetate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Axonal degeneration in the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Axonal pathology in multiple sclerosis: relationship to neurologic disability

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cop 1 therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2803%2900217-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-0102(03)00217-7

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44598086&oldid=2162106658"